7 days ago
INSM
AnalystsJessica FyeJessica Fye's Stock Forecasts
AnalystsJessica Fye
Analyst Ranking
Top 6%
#297 out of 4939 analysts
Average Return
+14.45%
Win Rate
61%77 out of 126
Risk vs Reward
Poor
Good
Jessica Fye's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-10 - 2024-02-23 | Strong Buy |
Insmed IncINSM | +199.43% | $24.62 | $73.72 | 2023-11-20 - 2024-11-19 | Strong Buy |
Stemline Therapeutics IncSTML | +178.35% | $4.25 | $11.83 | 2020-03-26 - 2020-06-10 | Strong Buy |
Ascendis Pharma AASND | +134.77% | $27.90 | $65.50 | 2017-05-11 - 2018-05-11 | Strong Buy |
Intra Cellular Therapies IncITCI | +93.36% | $68.20 | $131.87 | 2024-06-12 - 2025-04-01 | Strong Buy |
Jessica Fye Analyst Color
Get additional color on Jessica Fye's coverage of popular stocks
a month ago
ALNY
2 months ago
ASND
4 months ago
ALNY
4 months ago
ASND
5 months ago
INSM
6 months ago
ASND
8 months ago
INSM
8 months ago
ITCI
9 months ago
ONC
10 months ago
BMRN
a year ago
ASND
a year ago
ONC
a year ago
JAZZ
a year ago
DNLI
a year ago
INSM
a year ago
MIRM
a year ago
INSM
2 years ago
ITCI
2 years ago
LEGN
3 years ago
LEGN
3 years ago
VRTX
3 years ago
MRNA
3 years ago
IMCR
3 years ago
UTHR
Jessica Fye's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vertex Pharmaceuticals IncVRTX | 9 | Strong Buy | $517.00 | +9.45% | Maintains | a day ago |
Incyte CorpINCY | 7 | Hold | $67.00 | -4.26% | Maintains | a day ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $113.00 | +94.06% | Maintains | a day ago |
United Therapeutics CorpUTHR | 9 | Strong Buy | $330.00 | +10.86% | Maintains | 7 days ago |
Insmed IncINSM | 8 | Strong Buy | $111.00 | +8.94% | Maintains | 7 days ago |
Beone Medicines LtdONC | 6 | Strong Buy | $321.00 | +27.31% | Maintains | 18 days ago |
Ionis Pharmaceuticals IncIONS | 5 | Hold | $48.00 | +12.81% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 6 | Strong Buy | $338.00 | +7.05% | Maintains | a month ago |
Moderna IncMRNA | 13 | Strong Sell | $26.00 | -20.90% | Maintains | 2 months ago |
Biontech SeBNTX | 12 | Hold | $116.00 | +4.50% | Maintains | 2 months ago |
Biocryst Pharmaceuticals IncBCRX | 3 | Strong Buy | $13.00 | +45.09% | Maintains | 2 months ago |
Ascendis Pharma AASND | 11 | Strong Buy | $245.00 | +40.09% | Maintains | 2 months ago |
Halozyme Therapeutics IncHALO | 6 | Hold | $58.00 | +0.61% | Maintains | 3 months ago |
Immunocore Holdings PLCIMCR | 5 | Strong Buy | $50.00 | +41.64% | Maintains | 3 months ago |
Novocure LtdNVCR | 4 | Hold | $28.00 | +60.73% | Maintains | 3 months ago |
Jazz Pharmaceuticals PLCJAZZ | 4 | Strong Buy | $209.00 | +87.54% | Maintains | 5 months ago |
Denali Therapeutics IncDNLI | 5 | Strong Buy | $24.00 | +63.38% | Maintains | 6 months ago |
Intra Cellular Therapies IncITCI | 6 | Strong Buy | $89.00 | -32.51% | Maintains | 8 months ago |
Alkermes PLCALKS | 6 | Hold | $26.00 | -12.43% | Maintains | 9 months ago |
Mbx Biosciences IncMBX | 1 | Strong Buy | $30.00 | +116.29% | Initiates Coverage On | 9 months ago |
Crinetics Pharmaceuticals IncCRNX | 3 | Strong Buy | $54.00 | N/A | Maintains | a year ago |
Mirum Pharmaceuticals IncMIRM | 3 | Strong Buy | $39.00 | N/A | Maintains | a year ago |
Stoke Therapeutics IncSTOK | 2 | Hold | $13.00 | N/A | Maintains | a year ago |
Deciphera Pharmaceuticals IncDCPH | 4 | Hold | $16.00 | N/A | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 4 | Hold | $45.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 1 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Rayzebio IncRYZB | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $76.00 | N/A | Maintains | 2 years ago |
Emergent Biosolutions IncEBS | 1 | Strong Sell | $9.00 | N/A | Downgrades | 2 years ago |
Esperion Therapeutics IncESPR | 5 | Hold | $9.00 | N/A | Maintains | 2 years ago |
Seagen IncSGEN | 2 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Tricida IncTCDAQ | 2 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Nektar TherapeuticsNKTR | 5 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Amarin Corp PLCAMRN | 4 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Tvardi Therapeutics IncTVRD | 2 | Strong Buy | $240.00 | N/A | Upgrades | 3 years ago |
Landos Biopharma IncLABP | 2 | Hold | $70.00 | N/A | Maintains | 4 years ago |
Dianthus Therapeutics IncDNTH | 1 | Hold | $7.00 | N/A | Downgrades | 4 years ago |
Lava Therapeutics NvLVTX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Aptinyx IncAPTX | 1 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | $7.00 | N/A | Upgrades | 4 years ago |
Stemline Therapeutics IncSTML | 2 | Strong Buy | $8.00 | N/A | Maintains | 5 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $58.00 | N/A | Upgrades | 5 years ago |
Axcella Health IncAXLA | 2 | Strong Buy | $275.00 | N/A | Maintains | 6 years ago |
Aprea Therapeutics IncAPRE | 1 | Hold | $460.00 | N/A | Initiates Coverage On | 6 years ago |
Mersana Therapeutics IncMRSN | 4 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Strong Sell | $18.00 | N/A | Downgrades | 7 years ago |
Radius Health IncRDUS1 | 4 | Strong Buy | $52.00 | N/A | Maintains | 7 years ago |
Chimerix IncCMRX | 1 | Strong Sell | N/A | N/A | Downgrades | 7 years ago |
Enanta Pharmaceuticals IncENTA | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Advanced Accelerator Applications SaAAAP | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.